Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | # Peptides (by Search Engine): E2 Sequest HT (Liver IgG) | # Peptides (by Search Engine): F2 Sequest HT (Liver SKO) | # Peptides (by Search Engine): G2 Sequest HT (Liver WT) | # Peptides (by Search Engine): H2 Sequest HT (Liver HKO) | # PSMs (by Search Engine): E2 Sequest HT (Liver IgG) | # PSMs (by Search Engine): F2 Sequest HT (Liver SKO) | # PSMs (by Search Engine): G2 Sequest HT (Liver WT) | # PSMs (by Search Engine): H2 Sequest HT (Liver HKO) | Abundance: F5: Sample, Liver IgG | Abundance: F6: Sample, Liver SKO | Abundance: F7: Sample, Liver WT | Abundance: F8: Sample, Liver HKO | Abundances Count: F5: Sample, Liver IgG | Abundances Count: F6: Sample, Liver SKO | Abundances Count: F7: Sample, Liver WT | Abundances Count: F8: Sample, Liver HKO | Modifications | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Ensembl Gene ID | Gene Symbol | Chromosome | Reactome Pathways | KEGG Pathways | # Razor Peptides |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High | P83940 | Elongin-C OS=Mus musculus OX=10090 GN=Eloc PE=1 SV=1 | 0 | 34.754 | 66 | 7 | 53 | 7 | 112 | 12.5 | 4.78 | 2 | 4 | 3 | 3 | 3 | 4 | 3 | 3 | 3245403.25 | 2687874.859 | 3116346.297 | 1928559.914 | 3 | 6 | 3 | 5 | metabolic process;regulation of biological process | nucleus | catalytic activity;protein binding | Pf03931 | 67923; 102642819 | ENSMUSG00000079658.9 | Tceb1; Eloc; LOC101056616; LOC102642819 | 1; 2 | RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; Formation of RNA Pol II elongation complex ; Interleukin-7 signaling; Neddylation; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | Ubiquitin mediated proteolysis; HIF-1 signaling pathway; Pathways in cancer; Renal cell carcinoma | 0 |